Tyscon Pharmaceuticals Private Limited
About Tyscon Pharmaceuticals Private Limited
Data last updated:
Tyscon Pharmaceuticals Private Limited is a private limited company based in Zirakpur, Punjab, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U74999PB2018PTC047374. Its GSTIN is 03AAGCT5809D1ZM (Punjab).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nitin Goyal and Deepak Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 17 Opposite Tri City Homes Peermuchalla, Zirakpur, Punjab, India – 140603.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.4 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹4.26 Lakh (net margin 1.3%) and EBITDA of ₹11.42 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 22% over five years.
As per MCA filings, the company has open charges of ₹12 Lakh on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it; 2 cases are pending.
Company details
Contact details
Tyscon Pharmaceuticals Private Limited's registered office is in Zirakpur, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressScf 17 Opposite Tri City Homes Peermuchalla, Zirakpur, Punjab, India – 140603
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Tyscon Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Tyscon Pharmaceuticals Private Limited
FY 2025 filings availableTyscon Pharmaceuticals Private Limited reported revenue of ₹3.4 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 16% growth in the latest year. EBITDA rose 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.42 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tyscon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Tyscon Pharmaceuticals Private Limited
Tyscon Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Goyal Also directs: Amicable Pharmaceuticals Private Limited | Director | 09 Aug 2022 | 4 Years 2 Months | Current |
| Deepak Goyal Also directs: Amicable Pharmaceuticals Private Limited | Director | 12 Jan 2018 | 8 Years 9 Months | Current |
Peer comparison
Tyscon Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tyscon Pharmaceuticals Private Limitedthis company | ₹3.4 Cr (FY 2025) | ₹4.26 Lakh | 1.3% | 16.0% | Zirakpur, Punjab, India | |
| Maxzimaa Pharmaceuticals Private Limited | ₹3.4 Cr (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| Saach Pharmaceuticals Private Limited | ₹3.39 Cr (FY 2024) | 17.0% | Manimajra, Chandigarh, India | |||
| Foursa Medicare Private Limited | ₹3.39 Cr (FY 2025) | 15.0% | Meerut, Uttar Pradesh, India |
To see the full peer comparison of Tyscon Pharmaceuticals Private Limited, buy the company report.
Auditor
Tyscon Pharmaceuticals Private Limited is audited by R P KUMAR & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R P KUMAR & CO. | FY 2023 | 028150N |
Shareholding
The shareholding of Tyscon Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Tyscon Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Jun 2024 | 100932089 | Others | ₹12 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Tyscon Pharmaceuticals Private Limited has 5 court cases on record: 3 filed by Tyscon Pharmaceuticals, 2 filed against it. 2 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 2 |
| High courts | 1 | 1 | 0 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Alkem Laboratories Ltd. | Disposed |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Saidurga Enterprises and 2 others | Pending |
| District court, Darbhanga, Bihar | Court case (Gr Case) | Filed against the company by an individual | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Royal Medicose and 1 other | Disposed |
To see the full case history of Tyscon Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tyscon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tyscon Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAGCT5809D1ZM | Punjab | Active | 24 Feb 2018 |
To see the full GST registrations and return filing status of Tyscon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Tyscon Pharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Baldev Krishan Goyal ceased to be Director on 09 Aug 2022.
Frequently asked questions
Tyscon Pharmaceuticals is an active private limited company based in Zirakpur, Punjab, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 January 2018 (8+ years old) and is registered under CIN U74999PB2018PTC047374.
Tyscon Pharmaceuticals has 2 current directors:
- Nitin Goyal - Director
- Deepak Goyal - Director
The latest financial statements of Tyscon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Tyscon Pharmaceuticals is 03AAGCT5809D1ZM, registered in Punjab.
The CIN (Corporate Identification Number) of Tyscon Pharmaceuticals is U74999PB2018PTC047374. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tyscon Pharmaceuticals has 5 court cases on record: 3 filed by the company and 2 filed against it. 2 are pending. Most are in the district courts.
Tyscon Pharmaceuticals was incorporated on 12 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Tyscon Pharmaceuticals by revenue are Maxzimaa Pharmaceuticals Private Limited, Saach Pharmaceuticals Private Limited, Foursa Medicare Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Baldev Krishan Goyal ceased to be Director on 09 Aug 2022. Nitin Goyal was appointed as Director on 09 Aug 2022. Rohit Goyal ceased to be Director on 11 Jun 2022. Tyscon Pharmaceuticals has 4 board changes on record in total.
The registered office of Tyscon Pharmaceuticals is at Scf 17 Opposite Tri City Homes Peermuchalla, Zirakpur, Punjab, India – 140603.
Tyscon Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.